Bolt Biotherapeutics Financial Flexibility Index
Bolt Biotherapeutics financial flexibility index. Bolt Biotherapeutics (BOLT) has a Financial Flexibility Index of -0.24x as of December 2025. Free cash flow of $-7.16 Million (operating CF $-7.16 Million minus capex $0.00) represents 0% of total liabilities ($30.24 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Bolt Biotherapeutics (2018–2025)
Financial flexibility index of Bolt Biotherapeutics from 2018 to 2025. Historical Financial Flexibility Index trend for Bolt Biotherapeutics across 8 annual periods. Explore Bolt Biotherapeutics cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Bolt Biotherapeutics Financial Flexibility Index by Year (2018–2025)
Bolt Biotherapeutics financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Bolt Biotherapeutics. For the full cash flow conversion analysis, see Bolt Biotherapeutics cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.32x | $-39.78 Million | $-39.85 Million | $30.24 Million | ▲ +8.9% |
| 2024 | -1.44x | $-61.25 Million | $-61.29 Million | $42.43 Million | ▲ +2.0% |
| 2023 | -1.47x | $-69.32 Million | $-69.53 Million | $47.04 Million | ▼ -11.3% |
| 2022 | -1.32x | $-74.55 Million | $-76.50 Million | $56.30 Million | ▼ -39.4% |
| 2021 | -0.95x | $-54.73 Million | $-57.07 Million | $57.60 Million | ▼ -226.8% |
| 2020 | -0.29x | $-44.05 Million | $-47.31 Million | $151.49 Million | ▼ -6.1% |
| 2019 | -0.27x | $-25.84 Million | $-26.34 Million | $94.29 Million | ▲ +8.7% |
| 2018 | -0.30x | $-9.58 Million | $-9.87 Million | $31.92 Million | — |